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Abstract
Background: This paper summarizes the findings of a long term study addressing the question of how several
brain volume measure are related to three major mental illnesses in a Colorado subject group. It reports results
obtained from a large N, collected and analyzed by the same laboratory over a multiyear period, with visually
guided MRI segmentation being the primary initial analytic tool.
Methods: Intracerebral volume (ICV), total brain volume (TBV), ventricular volume (VV), ventricular/brain ratio (VBR),
and TBV/ICV ratios were calculated from a total of 224 subject MRIs collected over a period of 13 years. Subject
groups included controls (C, N = 89), and patients with schizophrenia (SZ, N = 58), bipolar disorder (BD, N = 51),
and schizoaffective disorder (SAD, N = 26).
Results: ICV, TBV, and VV measures compared favorably with values obtained by other research groups, but in this
study did not differ significantly between groups. TBV/ICV ratios were significantly decreased, and VBR increased, in
the SZ and BD groups compared to the C group. The SAD group did not differ from C on any measure.
Conclusions: In this study TBV/ICV and VBR ratios separated SZ and BD patients from controls. Of interest however,
SAD patients did not differ from controls on these measures. The findings suggest that the gross measure of TBV
may not reliably differ in the major mental illnesses to a degree useful in diagnosis, likely due to the intrinsic
variability of the measures in question; the differences in VBR appear more robust across studies. Differences in
some of these findings compared to earlier reports from several laboratories finding significant differences between
groups in VV and TBV may relate to phenomenological drift, differences in analytic techniques, and possibly the
“file drawer problem”.
Background
This paper addresses differences in several measures of
brain and ventricle volume and brain/intracranial volume
ratio in three major Axis I mental disorders including
schizophrenia (SZ), schizoaffective disorder (SAD), and
bipolar disorder (BD), based upon MRIs of the brain
obtained from 224 subjects over a period of 13 years in
the same laboratory. Originally obtained for the purpose
of providing brain structural data for neuroanatomical
source location of MEG determined functional sources,
this MRI data base is now being examined from a strictly
anatomical volumetric viewpoint, to compare data from
this subject population to similar reports in the published
literature to date.
Brain size and the ratio of brain size to total intracranial
volume has been a topic of interest since the advent of the
capacity to image the brain. The earliest imaging strategy,
pneumoencephalography, was introduced by Walter
Dandy, chief resident for William Halstead at Johns
Hopkins, in 1919, replacing cere b r a ls p i n a lf l u i d( C S F )
with air, which made it possible to study the contours and
major morphological changes in the brain directly [1].
Abnormalities in the earliest s t u d i e si np a t i e n t sw i t h
dementia and the organic psychoses, led Moore et al
suggested in 1935 that if similar changes could be demon-
strated in patients with the so-called “functional psychoses”
it would imply disturbances in brain function also underly-
ing these disorders [2]. These authors reported PEG result
in 71 patients with schizophrenia and 46 patients with
manic depressive psychosis. Evidence of cortical atrophy
was found “in the majority of patients with schizophrenia”
(p57), but in the cases of manic depressive psychosis these
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showed no consistent picture that would characterize
manic-depressive psychosis” (p61). Haug in 1962 [3]
reviewed PEG studies of schizophrenia to date, and added
101 new cases of schizophrenia, of which 73 had a diagno-
sis of definite or probable dementia as well, finding evi-
dence of abnormal PEGs in 58%, usually ventricular
dilatation or increased subarachnoid space suggestive of
cortical atrophy. In general, the early PEG studies were
complicated by relative lack of diagnostic clarity, absence
of controls, and the fact that patient populations were
most often chronically hospitalized and frequently demen-
ted individuals with many co morbidities, as well as poor
resolution and difficulty quantifying the imaging data.
The development of computerized axial tomography
greatly enhanced the capacity to visualize the outlines of
the brain and ventricular system and identify significant
structural abnormalities, although volumetric calcula-
tions were compromised by issues of slice thickness, and
difficulties estimating the volume of radiolucent CSF
(e.g. in the sulci). A review of 50 CT studies in schizo-
phrenia reported inconsistency (and diminution) of find-
ings over time, and the interesting observation that
studies in larger numbers of subjects appeared to less
often find significant differences compared to studies
with fewer subjects [4].
The subsequent development of magnetic resonance
imaging (MRI), in association with the dramatic increase
in computational capabilities including computerized
image analysis, led to an explosion of neuroanatomical
studies of brain structure in mental illness. As of the
date of this writing, a Medline search combining CT,
brain and schizophrenia retrieve 443 publications, and
brain, schizophrenia, and MRI return 1152 publications.
In the case of bipolar disorder, searches of bipolar disor-
der and manic depressive disorder, CT, and brain return
70 publications, and with MRI instead of CT, 228. Sali-
ent is the development of major data bases such as the
‘Internet Brain Volume Database’ [5] funded by ‘The
Human Brain Project’ which attempts to archive this
extensive volumetric data.
SZ, now generally considered to represent a neurode-
velopmental disorder, has been studied most intensively
in terms of brain volume changes. Findings were often
not consistent however. Earlier studies frequently sug-
gested fairly significant volumetric differences in patients
compared to controls; later studies usually with larger
Ns have often been more equivocal. In a 1999 review of
8 longitudinal MRI studies of brain structural changes
in SZ (which included a number of structures as well as
ventricle size), DeLisi [6] was only able to conclude that
changes in such variables appear greater across the life
span in subjects with SZ compared to controls, but the
specifics are highly variable.
The brain volume of patients with BD has been less
intensively studied.
A meta-analysis published by McDonald et al in 2004
systematically analyzed twenty six studies which investi-
gated volumetric measurement on up to 404 BD
patients [7]. Their conclusions established that the
volumes of most brain structures are preserved in BD
other than a noted association with right-sided ventricu-
lar enlargement.
No studies yet independently report brain volume or
brain/ICV ratio in SAD, which seems unusual for a disor-
der which, at least in the Denver public mental health
system, outnumbers SZ in frequency. There is no inde-
pendent MESH code for SAD, and when used as a key-
word, it is rather included under the terms schizophrenia
and disorders with psychotic features, perhaps related to
sparsity of published biomarkers specific to SAD.
This manuscript reports the findings from this group
of subjects addressing several areas, including 1) how
replicable is the evidence supporting altered brain
volume (BV) in these major mental disorders, 2) is there
evidence supporting altered intracranial volume (ICV,
the space available for the brain to fill) in these disor-
ders, 3) what is the evidence for altered ratios of BV to
ICV, suggesting BV may have changed after ICV devel-
oped, and 4) what is the evidence for altered VV and
VBR in these disorders.
The manuscript is based upon data collected with the
support of several NIH grants over approximately the
past 13 years, which offers advantages (relatively large
number of subjects, methodological consistency within
the same laboratory), and of course some possible pro-
blems (imaging equipment changes with time).
Methods
Subjects
We obtained MRI scans from a total of 224 subjects over
a time period of thirteen years, beginning in 1992. Sub-
jects were participants in one or more of two NIMH
funded R01 grants studying MEG based biological vari-
ables in mental disorders, and included individuals with
SZ (N = 58, 40 males), SAD (N = 26, 18 males), BD (N =
51, 24 males), as well as normal controls (C, N = 89,
42 males).
Patient subjects of any race between the age of 18 and
58 that met the DSM-IV criteria for BD, SAD or SZ that
were without the presence of a current or recent (past 3
mo) diagnosis of alcohol or substance abuse/dependence,
had no history of a neurological disorder (epilepsy,
stroke, traumatic brain injury, significant environmental/
toxic injury, other neurodevelopmental or neurodegen-
erative disorders, past meningitis/encephalitis, autism,
pervasive developmental disorder, or mental retardation),
or current major medical illness were eligible for the
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Denver metropolitan area and were in outpatient treat-
ment. Psychiatric diagnoses were based upon a formal
structured diagnostic interview (SCID-P) performed by
MR or a research assistant that had been trained to cri-
teria on SCID interview procedures with review of SCID
findings with MR. Comparison control subjects were
community volunteers with no history of mental illness
or neurological disease. Control subjects met criteria for
never mentally ill on the SCID-NP. All participants
completed the Annett Handedness Scale [8].
The majority of patient subjects were medicated. Most
SZ subjects were taking typical or atypical antipsycho-
tics, most BD patients taking mood stabilizers as well as
possibly antipsychotics, and SAD patients taking various
combinations of mood stabilizers and antipsychotics.
Demographic and medication data for the all subjects
are summarized in Table 1.
All experimental protocols were approved by the Col-
orado Multiple Institutional Review Board, and after the
studies had been fully explained to them, all subjects
were required to sign an informed consent. BD subjects
were studied in a euthymic state, as defined by a Hamil-
ton Depression Rating Scale score < 7, and Young
Mania Rating Scale score < 6.
MRI Data Acquisition
MRIs were obtained at one of three sites: including a GE
Signa 1.5 T (153 scans) scanner at the University of Col-
orado Hospital, a 1.5 T Philips NT (48 scans) scanner at
the Denver VAMC, and a GE 3.0 T (23 scans) MRI scan-
ner located within the Department of Psychiatry,
UCDenver. Standardized T1 weighted image protocols
(TR = 40 ms, TE = 5 ms) were used on all instruments,
imaging the head with 124 1.7 mm thick, contiguous
c o r o n a li m a g e s ,v o x e ld i m e n s i o n s0 . 9 4×0 . 9 4m m×
1.7 mm. The proportion of scans across the 3 scanners
among the 4 groups was not significantly different,
c
2 (6) = 11.12, p > .05.
A single investigator (ER) determined all intracranial
and brain volumes over the total course of the study.
Formal training in brain volume identification including
accurate delineation of the skull-CSF boundary was pro-
vided by a board certified neuroradiologist (ES). A com-
bination of manual and automated brain extraction
techniques based upon IDL software [9] was used to
identify and extract the intracranial volume and brain
volume contained within. Briefly, each slice in the coro-
nal series was displayed on the computer screen, and an
initial computer estimate of inner skull boundary, CSF,
and brain tissue in that slice based upon pixel intensity
values was performed automatically using the contour-
based thresholding function of IDL. Each resulting slice
with automated estimates was then visually examined
sequentially, slice by slice, in detail. The accuracy of the
inner skull border was determined visually, necessary
corrections were made using hand tracing, and the
resulting bone and tissue external to this boundary was
stripped leaving ICV containing brain and CSF for that
slice. Next the estimate of CSF - brain boundary was
examined and corrected visually by hand as necessary,
and CSF in that slice was removed, leaving brain tissue
for that slice. These functions were performed sequen-
tially for each brain MRI slice from front to back. The
entire procedure required approximately 3-4 hours for
each brain. A more detailed comment on methods for
identifying ICV boundaries can be found in appended
Additional file 1.
Additionally, subsequent processing was used to inde-
pendently separate ventricular from non-ventricular CSF
based upon several automated methods. Using FSL “Fast”
segmentation software [10], the brains (which had already
had all tissue external to the CSF-inner table boundary
removed) were segmented and the three tissue types, grey,
white and csf were classified by pixel value. Using high-
dimensional warping software “Hammer” [11] the images
were warped to a ventricle labeled brain template. Indivi-
dual subjects image volumes were then multiplied by the
inverse of the deformation field retained from the warp
into template space, resulting in ventricle volumes for
each subject in their original space. A ratio of brain
volume (with ventricular volume removed) to intracranial
volume (TBV/ICV), and ventricle/brain ratio (VBR) was
then computed for each subject.
Statistica 6.1 (Statsoft, Tulsa, OK) software was used
for data analysis. Null-hypothesis significance testing
was conducted at .05 alpha (two-tailed), using Type III
sums of squares. Differences in demographic variables
between groups were evaluated using separate one-way,
between groups ANOVA. The effect of scanner on MRI
Table 1 Group demographics
Characteristic Bipolar group Schizoaffective group Schizophrenic group Controls
Number of subjects 51 (24 males) 26 (18) males 58 (40 males) 89 (42 males)
Age (std dev) 40.65 (10.85) 36.37 (11.78) 39.22 (7.95) 34.34 (8.79)
Education years 14.45 (2.03) 13.30 (2.42) 12.94 (2.55) 15.26 (1.91)
Handedness (Annette score) 0.85 (0.14) 0.85 (0.27) 0.71 (0.49) 0.79 (0.36)
Number medicated 45 24 54 0
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examine the impact of gender on the MRI variables,
Independent Student’s t-tests were computed separately
for the dependent measures. To evaluate group effects
for the MRI variables, a one-way ANCOVA was con-
ducted separately for total brain volume (TBV), ventri-
cular volume (VV), intracranial volume (ICV) and the
ratio of brain volume to intracranial volume, using
gender and age as covariates for the analyses. Pearson
Product Moment Correlation Coefficients were used to
compute correlations between demographic variables
and MRI variables. Post-hoc analyses of group main
effects were conducted using Fisher’s Least Significant
Difference (LSD) tests. A one-way ANOVA as used to
examine VBR and diagnosis as the between subjects
factor.
Results
A summary of mean vales and standard deviations for
ICV, TBV, VV, VBR and TBV/ICV ratio are tabulated
in Table 2.
TBV, ICV and VBR did not significantly differ
between scanners. Given that and the lack of signifi-
cantly different proportions of patient groups between
the scanners, the scanner variable was not considered
further in subsequent analyses.
There were significant gender differences in all of the
volume measurements, but not for the TBV/ICV ratio
measure. For VV (not illustrated), TBV and ICV, men
had significantly larger volumes than women, t(222) =
4.63, p < .001, t(222) = 8.98, p < .001 and t(222) = 9.38,
p < .001, respectively. There was a significant difference
in age between groups, F(3, 220) = 6.02, p < .001. Post-
hoc analyses revealed that the C group (mean age 34.34
years) was significantly younger than the BD (40.65
years) and SZ (39.22 years) groups, p < .001 and p = .002
respectively. Age was significantly correlated with VV
(r = .25, p < .001), TBV (r = -.15, p < .05) and TBV/ICV
ratio (r = -.19, p = .005), but not with ICV (p = -.12,
p = .08). We therefore employed both age and gender as
covariates in subsequent analyses.
For TBV, the group main effect, although trending,
was formally statistically non-significant, F(3, 218) =
2.42, p = .07. Likewise, for ICV the group main effect
was non-significant, F(3, 218) = 1.62, p = .19. No group
differences in VV were observed, F(2, 218) = .81,
p = .49. For the TBV/ICV measure, the group main
effect was however significant, F(3,227) = 2.58, p = .05.
Post hoc analysis revealed that the TBV/ICV ratio in
both BD and SZ subjects were smaller than controls,
p = .007 and p = .005 respectively.
The ANOVA for VBR found that the diagnosis main
effect was significant, F(3,220) = 4.74, p = .003. Posthoc
LSD testing revealed that the BD and SZ groups had
significantly higher ratios than controls (p = .009 and
p = .001), but theSAD group was not significantly differ-
ent than C (p >.05). No other effects were significant.
Examination of the raw mean values for several of the
variables might suggest concordance with recently pub-
lished data for SZ. The SZ patients indeed demonstrated
smaller brains. The male SZ subjects had TBV 38 cc
(about 3%) smaller than male controls; females with SZ
had TBV 79 cc (about 6%) smaller than controls. ICV
values were also slightly smaller in the SZ groups how-
ever. None of these differences reached formal statistical
significance however reflecting intrinsic variability in the
Table 2 Means and standard deviations (SD) for intracranial volume (ICV), total brain volume (TBV), ventricular
volume (VV), ventricle/brain ratio (VBR), and brain volume/intracranial volume ratio (TBV/ICV)
Bipolar Subjects ICV TBV VV VBR TBV/ICV
Male (n = 24) Mean ± SD 1482.563 ± 138.828 1329.843 ± 129.378 31.51 ± 13.9 0.243 ± 0.0102 0.897 ± 0.030
Female (n = 27) Mean ± SD 1302.536 ± 112.330 1166.931 ± 110.786 21.77 ± 6.08 0.0192 ± 0.0056 0.895 ± 0.019
Total (n = 51) Mean ± SD 1387.255 ± 153.827 1243.596 ± 144.313 26.64 ± 10.05 0.0217 ± 0.0079 0.896 ± 0.025
Control Subjects ICV TBV VV VBR TBV/ICV
Male (n = 42) Mean ± SD 1489.755 ± 114.978 1354.338 ± 111.556 25.18 ± 9.90 0.0190 ± 0.0075 0.908 ± 0.018
Female (n = 47) Mean ± SD 1345.118 ± 116.599 1215.653 ± 105.602 20.99 ± 6.25 0.0176 ± 0.0048 0.903 ± 0.021
Total (n = 89) Mean ± SD 1413.374 ± 136.157 1281.100 ± 128.356 23.08 ± 8.07 0.0182 ± 0.0061 0.906 ± 0.020
Schizoaffective Subjects ICV TBV VV VBR TBV/ICV
Male (n = 18) Mean ± SD 1435.895 ± 118.635 1298.308 ± 101.764 26.33 ± 10.96 0.0208 ± 0.0084 0.904 ± 0.016
Female (n = 8) Mean ± SD 1328.658 ± 122.739 1196.083 ± 107.790 24.71 ± 4.40 0.0213 ± 0.0046 0.900 ± 0.015
Total (n = 26) Mean ± SD 1402.899 ± 127.814 1266.854 ± 112.296 25.52 ± 7.68 0.0210 ± 0.0065 0.903 ± 0.015
Schizophrenic Subjects ICV TBV VV VBR TBV/ICV
Male (n = 40) Mean ± SD 1464.978 ± 126.294 1315.718 ± 118.423 29.15 ± 0.36 0.0227 ±0.073 0.898 ± 0.018
Female (n = 18) Mean ± SD 1263.270 ± 123.169 1136.627 ± 133.719 24.24 ± 8.66 0.0217 ± 0.0068 0.898 ± 0.027
Total (n = 58) Mean ± SD 1402.379 ± 158.788 1260.138 ± 148.032 26.69 ± 9.01 0.0222 ± 0.0071 0.898 ± 0.021
Volumes in ml.
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larger than controls; BP females had brains 43 cc smal-
ler than controls, and ventricular volumes were not dif-
ferent. Both male and female schizoaffective subjects
had smaller raw mean BV than controls, but again the
differences were not significant statistically, and their
slightly smaller ICVs led to their BV/ICV ratios being
essentially identical to controls. Their VV did not differ
from controls. It is clear that rigorous statistical control
exerts significant influence on the interpretation of
means such as these in such subject cohorts.
We have included additional figures (Additional files 2,
3, 4 &5) containing raw data sets which illustrate the
relationship of values for 1) brain volume, 2) ventricle/
brain ratio, 3) ventricular CSF volume, and 4) brain/ICV
ratio to age.
Discussion
Several issues must be considered as we discuss these find-
ings. First might be how do our absolute values compare
with previous published findings in the medical literature
for these subject groups. For comparison, we chose recent
publications utilizing thin contiguous MRI slices.
Comparisons of control volumes
With respect to control subjects, we examined how our
values for TBV and ICV compare to TBV and ICV
values extracted from 5 other published studies invol-
ving 243 normal subjects (comparison studies include
those of Tanskannen [12], Narr [13], Arango [14],
Matsumae [15], and Blatter [16] These comparisons are
illustrated in Table 3.
Our ICV and TBV means for both males and females
were contained within the range of the means of these stu-
dies. Our ICV values differed by 0.3% in males, and 1.6%in
females; for TBV our results differed by 0.2% in males, and
1.2% in females. All in all therefore, we believe the ICV
and TBV in the control subjects in our study compare
favorably with those reported by other investigators.
Comparisons of schizophrenia volumes
We compared our findings in patients with schizo-
phrenia to published values in 3 other recent studies
reporting both BV and ICV in schizophrenia, those of
Narr, [13], Arrango, [14], and Tanskanen [12]. These
comparisons are illustrated in Table 4.
Our values for both ICV and TBV are quite compar-
able with these other published values. The standard
deviation in the several studies are all quite similar, and
generally large - in the vicinity of 100-150 cc or about
8-12% of total brain volumes. For illustrative purposes,
the mean of the means are also tabulated for compari-
son with individual study values.
Harrison in a 1999 review of the neuropathology of
schizophrenia comments that despite over a hundred
years of research on the topic, specifics remain obscure,
with studies using meta-analyses most often supporting
evidence of increased ventricular volume and selected
decreases (cortex and hippocampus) in brain volume
[17]. Interestingly however, in the Harrison meta-analysis
this difference did not emerge until the 50-60yo age
group of men, and was equivocal in women before the
age of 70, and our subject population was younger.
A meta-analysis by Woods and colleagues utilized data
from 20 publications addressing ICV and TBV in SZ,
involving a total of 1049 controls and 982 patients with
TBV data, and 942 controls and 889 patients with extra
cerebral volume (ECV). SZ patients demonstrated a
TBV reduction of 34cc, and ECV increase of 14.1cc
[18]. These differences, while statistically significant,
were small, pointing out that a very large N is necessary
to establish such small differences as being significant.
With brain volumes generally in the 1200-1400cc range,
and standard deviations in the range of 100cc, a differ-
ence of 34cc represents about 3% of total TBV, or about
one third of one typical standard deviation.
In light of two large meta-analyses reporting similar
but quite small differences in TBV between NC and SZ
patients, the question arises of why the large majority of
early published studies utilizing relatively small Ns quite
frequently reported statistically significant differences in
relatively small subject groups. One issue is possible
phenotypic drift, wherein the type of patient included in
a given diagnostic cohort changes over time. Certainly
the chronically hospitalized and non-medicated (from
current standards) schizophrenic, possibly demented,
Table 3 Comparison charts for ICV and TBV - all in ml
Author Age range Control male ICV Control female ICV Control male TBV Control female TBV
Reite et al. this ms. 18-55 (N = 42) 1490 ± 115 (N = 47) 1345 ± 117 1354 ± 111 1216 ± 106
Tanskannen et al. 2009 33-35 (N = 60) 1150 ± 114 (N = 40) 1378 ± 91 1351 ± 101 1215 ± 88
Narr et al. 2003 33-35 (N = 15) 1363 ± 135 (N = 13) 1244 ± 89 1273 ± 129 1168 ± 81
Arango et al. 2008 33-35 (N = 34) 1545 ± 133 (N = 32) 1333 ± 95 1424 ± 137 1220 ± 91
Matsumae et al. 1996 24-80 (N = 26) 1469 ± 102 (N = 23) 1289 ± 111 1302 ± 112 1143 ± 105
Blatter et al. 1996 36-45 (N = 17) 1546 ± 104 (N = 23) 1358 ± 113 1407 ± 99 1246 ± 105
Mean of means 1494 1324 1352 1201
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ferent from the patients studied in this report, who are
taking the latest antipsychotic medications, often can
live independently, and are able to come to the lab by
themselves either driving or taking public transporta-
tion. Thus both living environments as well as treatment
medications of study populations differ substantially
over time. Rosenzweig [19]was one of the first to
demonstrate profound environmental effect on brain
structure, and the remarkable plasticity of the brain in
response to experience has been demonstrated on many
levels [20].
The possible role of medication has been difficult to
accurately determine. There appear to be differences in
the influence of typical versus atypical antipsychotics in
grey matter volume changes in schizophrenia [21], but
reflections in total brain volume have not been reported.
Older brain imaging studies tended to have less resolu-
tion because of slice thickness and related differences,
although presumably such would only increase the var-
iance in the data. Finally, might the “file drawer pro-
blem” [22] be playing a role, wherein only those studies
reaching formal statistical significance get published,
and the non-significant studies are relegated to the file
drawer never to see the light of day? To the extent such
a phenomena is present, the risk of meta-analyses being
adversely impacted is also increased. Unfortunately there
is yet no clear cut manner in which to examine the
potential relevance of these issues.
With respect to VBR, we found SZ subjects had values
significantly larger than controls, which is consonant
with much of the published literature. One of the first
observations in early imaging studies in SZ was evidence
of larger ventricles, although again as with other vari-
ables the effect size seems to have diminished with time
as Lewis has previously observed [4].
Comparison of bipolar volumes
The brain volume of patients with bipolar disorder has
been less intensively studied. In an earlier study Harvey,
comparing brain volume of 26 subjects with bipolar dis-
order with 48 schizophrenics and 34 controls, found no
difference between bipolars and controls, although the
schizophrenic group had smaller volumes [23]. Friedman
and colleagues studied cohorts of adolescents with
schizophrenia and bipolar disorder compared to con-
trols, and found evidence of decreases in brain volume
when both patient groups were compared to controls,
b u tt h ep a t i e n tg r o u p sd i dn o td i f f e rf r o me a c ho t h e r
[24]. Hoge et al reported a meta-analysis of 7 studies
meeting criteria and examining cerebral volume in bipo-
lar disorder, and concluded that there was no evidence
supporting reduced brain volume in bipolar disorder
[25]. A large meta-analysis published by McDonald et al
2004 systematically analyzed twenty six studies that
investigated volumetric measurement on up to 404
bipolar patients. Their conclusions established that the
volumes of most brain structures are preserved in bipo-
lar disorder other than a noted association with right-
sided ventricular enlargement [26]. Our bipolar findings
are not at variance with the aforementioned studies.
TBV/ICV ratio finding
We found the TBV/ICV ratio to be decreased slightly
but significantly in the SZ and BD (but not SAD)
cohorts. These values are illustrated in Figure 1.
The finding is generally consistent with a small reduc-
tion in brain volume somewhere along the course of an
illness, which, with preservation of the initial total ICV,
leads to a decrease in the ratio of the two. The differ-
ences we found were in fact quite small - about 1% - or
12cc for a 1200 cc brain. Assuming the value is correct,
its interpretation is uncertain, especially in light of little
previous data supporting brain volume reductions in
bipolar disorder, including this study.
Comparison of schizoaffective volumes
T h eS A Dg r o u pd i dn o ts i g n i f i c a n t l yd i f f e rf r o mt h e
normal control group on any variable. SAD is a diagno-
sis whose relationship to SZ or BD is not well under-
stood. The proper categorization of SAD remains an
enigma over seven decades after its initial description,
and literature reviews to date have been able to contri-
bute little clarity [27,28], and some investigators have
questioned the existence of the syndrome [29]. Abrams
and colleagues [30] provide an extensive recent review
of the history, phenomenology, neuropsychological, phy-
siological and genetic studies pertinent to SAD and con-
clude that the signs and symptoms of SAD cross
conventional categorical boundaries between affective
Table 4 Comparison charts for schizophrenic (Sz) volumes - all in ml
Author Age range Sz maleICV Sz female ICV Sz male TBV Sz female TBV
Reite et al, this ms. 18-55 (N = 40) 1465 ± 126 (N = 18) 1263 ± 123 1316 ± 118 1137 ± 134
Tanskannen et al. 2009 33-35 (N = 31) 1354 ± 125 (N = 23) 1365 ± 79 1328 ± 110 1182 ± 73
Narr et al. 2003 33-35 (N = 15) 1380 ± 118 (N = 10) 1237 ± 114 1268 ± 110 1152 ± 97
Arango et al. 2008 33-35 (N = 64) 1507 ± 154 (N = 21) 1332 ± 119 1365 ± 142 1209 ± 115
Mean of means 1426 1299 1319 1170
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that the study and treatment of SAD subjects would
likely benefit from a dimensional rather than a categori-
cal approach [30]. There is also an intrinsic confound in
the diagnosis of SAD insofar as that a patients initially
diagnosed as SZ may sometime later (perhaps years)
develop and affective component (e.g. mania or psycho-
tic depression) and thus the primary diagnosis may
change to SAD. Once a SAD diagnosis is made however,
it does not change to SZ.
Few published studies have examined SAD as an inde-
pendent entity on the psychotic spectrum. Gruber and
colleagues have suggested that relative preservation of
articulatory rehearsal in verbal working memory in SAD
as compared to SZ may constitute a neurocognitive
endophenotype separating SAD from SZ [31]. Martin
et al have suggested that there may be subdivisions
within the SAD classification based upon variation in
genetic and physiological measures relating to possible
endophenotypes [32,33]. We have recently published
MEG auditory evoked field based data supporting a bio-
logical difference between SAD and SZ possibly based
upon relative preservation of neocortical inhibitory
GABAergic interneuronal activity in SAD compared to
SZ [34]. Such published findings along with our obser-
vations in this report would support further evaluations
of SAD as a possible independent entity.
Methodological issues
The volumes reported in this paper were collected over
some period of time. To address the issue of reproduci-
bility and possible drift over time, we randomly selected
1 7o ft h eb r a i n se x t e n d i n go v e rat i m ep e r i o do f1 0
years. The brain volume initially obtained by the rater
(ER) was compared to the automated brain volumes
computed by the Brain Extraction Tool (not available
when the study started). An intraclass correlation coeffi-
cient (ICC) was computed between the two ratings on
this series of 17 scans, and the ICC was .95, indicating
both consistency among methods and lack of drift
over time.
Finally, the specific methods utilized to estimate brain
volume may well contribute significantly to overall volume
estimates obtained from an experimental cohort and such
methods have varied over time. For example earlier MRI
studies frequently had relatively thick (e.g. 3-5 mm) some-
times non-contiguous slices which would contribute to
variability of outcome measures. As computer power
increased and image analysis software became more
sophisticated, visually guided hand based cutting of struc-
tures, which is intrinsically very labor intensive, has been
largely replaced by computerized image analysis with
sophisticated algorithms based upon pixel intensity and
rules of logic greatly facilitating automated analysis. Such
methods lead to greater opportunity find specific brain
regions associated with specific conditions at the expense
of far greater statistical complexity as well as some uncer-
tainty about accuracy of computer delineated structural
volumes based primarily upon logic and pixel intensity.
We believe this study may be the largest utilizing thin con-
tiguous MRI slices and visually guided segmentation of the
entire brain. Clearly such methodological differences may
contribute to some of the variability of results reported in
the literature, although precisely how much would be very
difficult to estimate.
Conclusions
In conclusion this study, although including a sizeable
number of subjects, failed to demonstrate statistically sig-
nificant differences in TBV between the three major
Figure 1 BV/ICV ratio in the four subject groups. Both bipolar and schizophrenic groups had a significantly lower ratio than control;
schizoaffective subjects dif not differ from controls.
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Page 7 of 9groups of severe mental illness studied, although two
groups (SZ and BD) demonstrated increased VBR, and the
same two group demonstrated slight increases in TBV/
ICV ratios. Although absolute raw data indicated brains in
male SZ subjects were about 3% smaller than control
brains, this failed to reach formal statistical significance.
No findings in SAD subjects differed significantly from
NC subjects, which along with other data discussed sug-
gest further studies of SAD as a separate entity on the psy-
chotic spectrum might be warranted. These findings
should not, or course, be interpreted as supporting no dif-
ference in intrinsic brain structure in the psychotic disor-
ders, as more refined neurohistological and computer
derived neuroanatomical parcellation have suggested that
such differences both exist and may be replicable, espe-
cially in SZ [35]. It may be some time however until such
findings are useful in the definition of the single subject’s
pathology, treatment planning, and prognosis.
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